Anticoagulation for atrial fibrillation: Should warfarin be temporarily stopped or continued after acute cardioembolic stroke?

Age and Ageing

Volumn 39, Issue 6, 2010, Pages 670-673

  Mudd, Paul D ^a   James, Martin A ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Elderly; Haemorrhage; Stroke; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; HEPARIN; PLACEBO; WARFARIN;

ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RISK BENEFIT ANALYSIS; RISK REDUCTION; TREATMENT DURATION;

ACUTE DISEASE; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; EVIDENCE-BASED MEDICINE; HUMANS; INTRACRANIAL EMBOLISM; MALE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STROKE; WARFARIN;

EID: 77958556801     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afq110     Document Type: Article

References (17)

1. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Eng J Med 1995; 333: 5-10.
2. Hallevi H, Albright KC, Martin-Schild S et al. Anticoagulation after cardioembolic stroke. Arch Neurol 2008; 65: 1169-73.
3. Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke, 3rd edition. London: Royal College of Physicians, 2008.
4. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
5. Adams HP, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38: 1655-711.
6. Chinese Acute Stroke Trial CAST. Randomised placebocontrolled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 34: 1641-9.
7. Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333-7.
8. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
9. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study (HAEST). Lancet 2000; 355: 1205-10.
10. Camerlingo M, Salvi P, Belloni G, Gamba T, Cesana BM, Mamoli A. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 2005; 36: 2415-20.
11. O'Donnell MJ, Berge E, Sandset PM. Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin? Stroke 2006; 37: 452-5.
12. Berger C, Fiorelli M, Steiner T et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001; 32: 1330-5.
13. Paciaroni M, Agnelli G, Corea F et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors and influence on clinical outcome. Results of a prospective multicenter study. Stroke 2008; 39: 2249-56.
14. Sandercock PAG, Counsell C, Kamal AK. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2008, Issue 4, Art. No.: CD000024.
15. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 2007; 38: 423-30.
16. Hart RG, Palacio S, Pearce LA. Atrial fibrillation, stroke and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 2002; 33: 2722-7.
17. Chamorro A, Vila N, Ascaso C, Blanc R. Heparin in acute stroke with atrial fibrillation. Clinical relevance of very early treatment. Arch Neurol 1999; 56: 1098-102.